Joseph Beaulieu

Insider Reports History

Entity
Individual
Location
C/O Epizyme, Inc., 400 Technology Square, Cambridge, MA
Signature
/s/ John Weidenbruch, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph Beaulieu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Epizyme, Inc. Senior Vice President, Finance and Corporate Controller Common Stock, par value $0.0001 0 $1.41 Aug 12, 2022 Direct
Epizyme, Inc. Senior Vice President, Finance and Corporate Controller Stock Option (Right to Buy) 0 Aug 9, 2022 Direct

Insider Reports Filed by Joseph Beaulieu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EPZM Epizyme, Inc. Aug 12, 2022 2 $0 4 Aug 16, 2022 Senior Vice President, Finance and Corporate Controller
EPZM Epizyme, Inc. Aug 9, 2022 3 $28K 4 Aug 11, 2022 Senior Vice President, Finance and Corporate Controller
EPZM Epizyme, Inc. Mar 17, 2022 2 $2.95K 4 Mar 21, 2022 Senior Vice President, Finance and Corporate Controller
EPZM Epizyme, Inc. Feb 7, 2022 1 -$333 4 Feb 9, 2022 Corporate Controller
EPZM Epizyme, Inc. Feb 2, 2022 1 -$941 4 Feb 4, 2022 Corporate Controller
EPZM Epizyme, Inc. Aug 16, 2021 2 $0 4 Aug 18, 2021 Corporate Controller